Investing Profile

Marianne Uteng

VC
Managing Director at Novartis Venture Fund
Photo of Marianne Uteng, Managing Director at Novartis Venture Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Novartis Venture Fund Managing Director
$5.0M - $10.0M
$7.5M
6
$750M
CompanyStageDateRound SizeTotal Raised
Epsilogen
Series BSep 2024$16M
Series BMar 2022$41M
$63M
Co-investors: Christoph Ruedig (Albion VC), Marianne Bjørdal (3B Future Health Ventures (Helsinn Investment Fund))
CatalYm
Series DJul 2024$150M
Series CNov 2022$52M
$200M
Co-investors: Colleen Cuffaro (Canaan Partners), Jon Edwards (Red Tree Venture Capital), Jonathan Tobin (Brandon Capital Partners), Oscar Slotboom (BGV (BioGeneration Ventures)), Nathalie Weitemeyer (Bayern Kapital), Rogier Rooswinkel (Forbion)
AstronauTx
Series AOct 2023$59M
$60M
Co-investors: Simon Goldman (Albion VC), Jonathan Tobin (Brandon Capital Partners), Laurence Barker (SV Health Investors)
Tagworks Pharmaceuticals
Series AJun 2023$65M
$65M
Co-investors: Michele Park (New Enterprise Associates (NEA)), Christina Isacson (Lightstone Ventures)